Future FinTech files for up to $200M in shelf offerings
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Future FinTech Group Inc. filed a preliminary shelf prospectus covering up to $200,000,000 in aggregate initial offering price of common stock, preferred stock, warrants, rights and units, to be offered from time to time after the registration statement becomes effective. Specific terms and prices would be set in offering supplements. While public float remains below $75 million, primary sales under the prospectus are limited to one-third of public float in any 12-month period. Unless a supplement says otherwise, proceeds are intended for general corporate purposes.
For 2025, the company reported $3,829,805 in revenue and a $30,946,254 net loss from continuing operations; operating cash flow from continuing operations was negative $31.77 million, and the auditor's report cited substantial doubt about continuing as a going concern. Management identified a material weakness in internal controls as of December 31, 2025, related to limited U.S. GAAP and SEC reporting experience. The company said it is still processing CSRC filings for prior offerings since the rules took effect; failures could draw fines of RMB1 million to RMB10 million.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Major pointFY2025 continuing-operations net loss was $30,946,254, and operating cash flow from continuing operations was negative $31.77 million; the auditor cited substantial doubt about the company's ability to continue as a going concern.
- Major pointManagement identified a material weakness in internal control as of December 31, 2025, related to limited U.S. GAAP and SEC reporting experience.
Filing Explained
No preferred stock is outstanding; the board may later set voting or conversion rights without a shareholder vote, affecting common holders.
This remains a preliminary shelf registration, not a completed issuance.
The company reports a public float of approximately
No preferred stock was outstanding as of
Key Figures
Key Terms
shelf registration financial
General Instruction I.B.6 regulatory
substantial doubt about our ability to continue as a going concern financial
material weakness technical
New Overseas Listing Rules regulatory
statutory reserve financial
Offering Details
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much can FTFT offer under its shelf prospectus?
What were FTFT's 2025 revenue and net loss?
When must FTFT complete CSRC filings for an offering?
How does FTFT expect to use proceeds from the shelf?
AI-generated analysis. How Rhea-AI works. Not financial advice.
As filed with the Securities and Exchange Commission on November 18, 2026.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-3
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
FUTURE FINTECH GROUP INC.
(Exact Name of Registrant as Specified in Its Charter)
| Florida | 98-0222013 | |
| (State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification Number) |
02B-03A, 23/F, Sino Plaza, 255-257 Gloucester Road
Causeway Bay, Hong Kong
852-21141970
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
Cogency Global Inc.
122 East 42nd Street, 18th Floor
New York, NY 10168
Phone: (800) 221-0102
Fax: (800) 944-6607
(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)
Copies to:
Jeffrey Li
FisherBroyles, LLP
1200 G Street, NW, Suite 800
Washington, D.C. 20005
(202) 830-5905
Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement.
If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
If this form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to rule 413(b) under the Securities Act, check the following box. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
| Large accelerated filer ☐ | Accelerated filer ☐ |
| Non-accelerated filer ☒ | Smaller reporting company ☒ |
| Emerging growth company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. ☐
The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities, and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED November 18, 2026
PRELIMINARY PROSPECTUS

Future FinTech Group Inc.
$200,000,000
Common Stock
Preferred Stock
Warrants
Rights
Units
We may offer from time to time shares of our common stock, par value $0.001 (“Common Stock”), preferred stock, warrants, rights and units that include any of these securities. The aggregate initial offering price of the securities sold under this prospectus will not exceed $200,000,000. We will offer the securities in amounts, at prices and on terms to be determined at the time of the offering.
This prospectus provides a general description of the securities we may offer. Each time we offer securities, we will provide the specific terms of the securities in one or more supplements to this prospectus. The prospectus supplements may also add, update or change information contained in this prospectus. You should carefully read this prospectus and any applicable prospectus supplement, as well as the documents incorporated by reference, before you invest in any of our securities. This prospectus may not be used to consummate a sale of securities unless accompanied by the applicable prospectus supplement.
Our common stock is listed on the Nasdaq Capital Market under the symbol “FTFT.” On November 17, 2026, the last reported sale price of our common stock on the Nasdaq Capital Market was $3.46 per share. The applicable prospectus supplement will contain information, where applicable, as to any other listing on the Nasdaq Capital Market or any securities market or other exchange of the securities covered by the prospectus supplement.
As of November 17, 2026, the aggregate market value of our outstanding common stock held by non-affiliates was approximately $20.87 million, based on 8,674,730 shares of outstanding common stock, of which 6,030,511 shares were held by non-affiliates, and a price of $3.46 per share, which was the last reported sale price of our common stock on the Nasdaq Capital Market on November 17, 2026. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities registered on this registration statement in a public primary offering with a value exceeding more than one-third of our public float in any 12-month period so long as our public float remains below $75,000,000. During the 12 calendar months prior to and including the date of this prospectus, we have not offered and sold any securities pursuant to General Instruction I.B.6 of Form S-3.
We are a smaller reporting company under applicable federal securities laws and are subject to reduced public company reporting requirements. Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 3 of this prospectus, in the applicable prospectus supplement and in the documents incorporated by reference into this prospectus.
Future FinTech Group Inc. is not a Chinese operating company but a holding company incorporated in Florida with no material operations of its own. We conduct our business through our subsidiaries, a substantial portion of which are located in the People’s Republic of China (“PRC” or “China”) and Hong Kong. Investors in our securities are purchasing an interest in a Florida holding company, not in our operating subsidiaries. This structure involves unique risks to investors. We previously had contractual arrangements with a variable interest entity (“VIE”) in China, Cloud Chain E-Commerce (Tianjin) Co., Ltd.; we completed the deregistration and dissolution of the VIE on March 7, 2024, and we do not currently use a VIE structure.
There are legal and operational risks associated with being based in and having a substantial majority of operations in China and Hong Kong. These risks could result in a material change in our operations and/or the value of our securities, or could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and cause the value of our securities to significantly decline or be worthless. The PRC government has recently initiated a series of regulatory actions and statements to regulate business operations in China with little advance notice, including cracking down on illegal activities in the securities market, enhancing supervision over China-based companies listed overseas, adopting new measures to extend the scope of cybersecurity reviews, and expanding efforts in anti-monopoly enforcement. See “Prospectus Summary — Permissions and Approvals Required from PRC Authorities” and “Risk Factors.”
Under the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Enterprises issued by the China Securities Regulatory Commission (“CSRC”), which took effect on March 31, 2023 (the “New Overseas Listing Rules”), we are required to complete filing procedures with the CSRC in connection with offerings of our securities. As of the date of this prospectus, we are still processing the filings with the CSRC for our prior offerings since the effectiveness of the New Overseas Listing Rules and have not yet complied with the filing requirements, which could subject us to fines ranging from RMB1 million to RMB10 million and other penalties. We will be required to complete the CSRC filing procedures within three business days after the completion of any offering under this prospectus.
Our auditor, Wei, Wei & Co., LLP, is headquartered in New York City and is currently subject to inspection by the Public Company Accounting Oversight Board (“PCAOB”). If the PCAOB determines in the future that it is unable to inspect or investigate our auditor completely for two consecutive years, trading in our securities may be prohibited under the Holding Foreign Companies Accountable Act, as amended, and our securities may be delisted.
As of the date of this prospectus, no dividends or distributions have been made between our holding company and its subsidiaries, or to investors, including U.S. investors. We do not have cash management policies that dictate how funds are transferred through our organization. To the extent cash or assets of our business are in the PRC or Hong Kong or held by a PRC or Hong Kong entity, such funds or assets may not be available to fund operations or for other use outside of the PRC or Hong Kong due to interventions in or the imposition of restrictions and limitations on our or our subsidiaries’ ability to transfer cash or assets by the PRC government. See “Prospectus Summary — Cash Transfers and Dividend Distributions.”
We may offer and sell securities to or through one or more underwriters, dealers or agents, or directly to purchasers, on a continuous or delayed basis. The names of any underwriters, dealers or agents and any applicable commissions or discounts will be set forth in the applicable prospectus supplement. See “Plan of Distribution.”
Investing in our securities involves certain risks. See “Risk Factors” beginning on page 3 of this prospectus. In addition, see “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025. You should carefully read and consider these risk factors before you invest in our securities.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus is [●], 2026.
TABLE OF CONTENTS
| About This Prospectus | ii | |
| Prospectus Summary | 1 | |
| Risk Factors | 3 | |
| Cautionary Note Regarding Forward-Looking Statements | 5 | |
| Use of Proceeds | 6 | |
| Description of Capital Stock | 6 | |
| Description of Warrants | 9 | |
| Description of Rights | 11 | |
| Description of Units | 12 | |
| Plan of Distribution | 12 | |
| Enforceability of Civil Liabilities | 13 | |
| Legal Matters | 14 | |
| Experts | 14 | |
| Where You Can Find More Information | 14 | |
| Incorporation of Certain Information by Reference | 15 |
i
ABOUT THIS PROSPECTUS
This prospectus is part of a registration statement on Form S-3 that we filed with the Securities and Exchange Commission (the “SEC”) using a “shelf” registration process. Under this shelf registration process, we may, from time to time, sell any combination of the securities described in this prospectus in one or more offerings up to a total aggregate offering price of $200,000,000, subject to the limitations of General Instruction I.B.6 of Form S-3.
Each time we sell securities under this shelf registration, we will provide a prospectus supplement that will contain specific information about the terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus supplement and any related free writing prospectus may also add, update or change information contained in this prospectus or in the documents incorporated by reference. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement, you should rely on the prospectus supplement.
We have not authorized anyone to provide you with information other than that contained or incorporated by reference in this prospectus, any applicable prospectus supplement and any free writing prospectus prepared by or on behalf of us. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. You should assume that the information appearing in this prospectus is accurate only as of the date on its cover and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference.
Unless the context otherwise requires, references in this prospectus to “we,” “us,” “our,” the “Company” or “Future FinTech” refer to Future FinTech Group Inc., a Florida holding company, together with its direct and indirect subsidiaries, and “Future FinTech Group Inc.” refers only to the Florida holding company. “PRC” or “China” refers to the People’s Republic of China, and, solely for purposes of this prospectus, excludes Taiwan and, except where the context requires, Hong Kong and Macau. All share and per share data in this prospectus reflect the 1-for-10 reverse stock split effected in April 2025, the 1-for-4 reverse stock split effected in January 2026, the 1-for-4 reverse stock split effected in July 2026 and the 1-for-4 reverse stock split effected in August 2026.
ii
PROSPECTUS SUMMARY
This summary highlights selected information contained elsewhere or incorporated by reference in this prospectus and does not contain all of the information you should consider before investing. You should read the entire prospectus, the applicable prospectus supplement and the documents incorporated by reference, including the “Risk Factors” sections and our financial statements and related notes, before making an investment decision.
Overview
Future FinTech Group Inc. is a holding company incorporated under the laws of the State of Florida. We historically engaged in the production and sale of fruit juice concentrates and fruit beverages in the PRC. Due to increased production costs and tightened environmental laws in China, we transformed our business from fruit juice manufacturing and distribution to financial technology related service businesses.
As of December 31, 2025, our principal business operations consisted of: (i) the sale of fast-moving consumer goods (“FMCG”) through an online store on an e-commerce platform, focusing on non-alcoholic and dairy beverages; (ii) trading commission and consulting services, including brokerage and investment banking services in Hong Kong conducted through FTFT International Securities and Futures Limited, which holds Type 1, Type 2 and Type 4 licenses issued by the Hong Kong Securities and Futures Commission, and listing readiness and preparatory consulting services; and (iii) supply chain financing and trading in China, which we significantly scaled down during 2025.
For the year ended December 31, 2025, we generated total revenue of $3,829,805, consisting of $3,259,845 from FMCG, $568,611 from trading commission and consulting services and $1,349 from supply chain financing/trading, and we incurred a net loss from continuing operations of $30,946,254. Our independent registered public accounting firm’s report on our consolidated financial statements for the year ended December 31, 2025 contains an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern.
Recent Developments
| ● | Dispositions. During 2024 and 2025 we exited a number of businesses, including our Hong Kong asset management business (Nice Talent Asset Management Limited, sold in November 2024), our cryptocurrency mining business (FTFT SuperComputing Inc., sold in December 2024), various subsidiaries sold in a court-ordered auction in connection with the FT Global litigation, and Future Commercial Management (Hainan) Co., Ltd., which we disposed of on December 16, 2025 for RMB10 million (approximately $1.4 million). |
| ● | Proposed Acquisition. In September 2025, our board of directors approved a proposal to pursue a potential acquisition of TansGen SC Tech Limited. On May 8,2026, the proposed acquisition of TansGen SC Tech Limited was terminated, and the Company is currently searching for other suitable acquisition targets. Approximately $31.39 million was held in escrow with a third party for future acquisition target. |
| ● | FT Global Settlement. On June 17, 2025, we entered into a Settlement and Forbearance Agreement with FT Global Capital, Inc. to resolve federal court judgments, providing for cash payments totaling approximately $4.0 million over 18 months and the issuance of shares of common stock pursuant to Section 3(a)(10) of the Securities Act. |
| ● | Reverse Stock Splits. The Company effected a 1-for-10 reverse stock split on April 1, 2025, a 1-for-4 reverse stock split on January 8, 2026, a 1-for-4 reverse stock split on July 10, 2026 and a 1-for-4 reverse stock split on August 26, 2026 to address the Nasdaq minimum bid price requirement. |
1
Our Corporate Structure
Future FinTech Group Inc. currently has one directly controlled subsidiary, Future FinTech (Hong Kong) Limited, a company incorporated under the laws of Hong Kong, through which we hold our operating subsidiaries in Hong Kong and the PRC. Our organizational structure as of the date of this prospectus is set forth in the diagram:

Permissions and Approvals Required from PRC Authorities
In the opinion of our PRC counsel, Fengdong Law Firm, our subsidiaries incorporated and operating in mainland China have received all required permissions from Chinese authorities to operate their current business in China, including business licenses and bank account opening permits, and we and our subsidiaries in China are not currently subject to permission requirements from the CSRC, the Cyberspace Administration of China (“CAC”) or any other entity that is required to approve their operations, and have not received or been denied such permissions by any PRC authorities. However, we are required to file with the CSRC for offerings under the New Overseas Listing Rules, and we have not yet completed such filings for our offerings since those rules took effect.
If we or any of our subsidiaries do not receive or maintain required permissions or approvals, inadvertently conclude that such permissions or approvals are not required, or applicable laws, regulations or interpretations change and we are required to obtain such permissions or approvals in the future, it could significantly limit or completely hinder our ability to offer or continue to offer our securities to investors and cause the value of our securities to significantly decline or become worthless.
Cash Transfers and Dividend Distributions
As a holding company, we may rely on dividends and other distributions on equity paid by our subsidiaries for our cash and financing requirements. Cash proceeds raised from overseas financing activities, including offerings under this prospectus, may be transferred by us to our PRC subsidiaries via capital contribution or shareholder loans. As of the date of this prospectus, no dividends or distributions have been made between the holding company and its subsidiaries, or to investors, including U.S. investors, and we have no plan to distribute dividends in the foreseeable future.
Current PRC regulations permit our PRC subsidiaries to pay dividends only out of their accumulated profits, if any, determined in accordance with PRC accounting standards, and each PRC subsidiary is required to set aside at least 10% of its after-tax profits each year to fund a statutory reserve until such reserve reaches 50% of its registered capital. If we are considered a PRC resident enterprise for tax purposes, dividends we pay to overseas shareholders may be subject to PRC withholding tax at a rate of up to 10%.
Corporate Information
Our principal executive offices are located at 02B-03A, 23/F, Sino Plaza, 255-257 Gloucester Road, Causeway Bay, Hong Kong, and our telephone number is 852-2114-1970. Our website is www.ftft.com. Information contained on, or accessible through, our website is not incorporated by reference into and does not form part of this prospectus.
2
RISK FACTORS
Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks described below and under the heading “Risk Factors” in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, as updated by our subsequent filings under the Exchange Act, which are incorporated by reference into this prospectus, and the risk factors in any applicable prospectus supplement. The occurrence of any of these risks could cause you to lose all or part of your investment.
Risks Related to Our Securities and Any Offering
There is substantial doubt about our ability to continue as a going concern.
We incurred operating losses from continuing operations of $30.95 million and negative operating cash flows from continuing operations of $31.77 million for the year ended December 31, 2025, and our auditor’s report includes an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern depends on our ability to raise additional capital and execute our business strategy. If we cannot continue as a going concern, investors could lose their entire investment.
We have broad discretion in the use of the net proceeds of any offering and may not use them effectively.
Our management will have broad discretion in the application of the net proceeds from any offering under this prospectus, and you will not have the opportunity to assess whether the proceeds are being used appropriately. Our failure to apply these funds effectively could harm our business and cause the price of our securities to decline.
You may experience immediate and substantial dilution, and future sales or issuances of our securities could cause our stock price to decline.
The offering price per share of common stock in an offering may exceed the net tangible book value per share of our outstanding common stock. In addition, we have issued and may continue to issue shares under convertible notes, pre-paid purchase arrangements and the FT Global settlement, and may issue additional equity in connection with any potential future acquisitions, each of which could result in significant dilution.
Our controlling shareholder has substantial influence over us, and he is the subject of a pending SEC enforcement action relating to trading in our stock. That action has led to securities litigation against us and could harm our business, reputation, financing ability and stock price.
Mr. Shanchun Huang indirectly owns 2,640,625 shares of Common Stock of the Company through Wealth Index Capital Limited (“WICL”) or 30.4% of our outstanding common stock as of the date of this prospectus. As a result, Mr. Huang can significantly influence, and may be able to control, matters submitted to our shareholders. These include the election and removal of directors, amendments to our articles of incorporation, mergers, and sales of all or substantially all of our assets. Under our articles, a director may be removed only by holders of a majority of the combined voting power of our outstanding voting shares. His ownership may therefore let him block the removal of directors or a change of control that other shareholders favor. His interests may also differ from yours. The SEC has filed charges against Mr. Huang. It alleges that he engaged in manipulative trading in our common stock through an offshore account shortly before he became our Chief Executive Officer in 2020, and that he failed to disclose his beneficial ownership of our shares. Mr. Huang has denied the allegations. The Company is not a defendant in the SEC action. However, the action has given rise to claims of a putative securities class action and three shareholder derivative actions against the Company. The SEC action and these lawsuits could adversely affect us. An adverse judgment in the class action, or a settlement, could require large payments. We are incurring, and expect to keep incurring, legal fees and costs to defend against these matters. We may also have to advance or reimburse expenses to current and former directors and officers under our indemnification obligations. Given our limited cash and the substantial doubt about our ability to continue as a going concern, any such payments could materially harm our financial condition. Responding to these matters, including any SEC requests for information or documents, may divert management’s time and attention from running our business. The allegations and resulting publicity could damage our reputation with customers, suppliers, regulators and financing sources. They could also cause counterparties, underwriters, placement agents or investors to decline to do business with us, or to do so only on less favorable terms. This would make it harder to raise capital under this registration statement or otherwise.
3
We cannot predict the outcome or timing of the SEC action, the class action or the derivative action. Any of these matters, alone or together, could materially and adversely affect our business, financial condition, results of operations and the market price of our common stock.
The market price of our common stock is volatile, and we may not maintain our Nasdaq listing.
We have received Nasdaq minimum bid price deficiency notices and have effected multiple reverse stock splits since April 2025. There can be no assurance that our common stock will remain in compliance with Nasdaq’s continued listing requirements. A delisting could materially adversely affect the liquidity and market price of our securities and our ability to raise capital.
Our ability to sell securities under this registration statement is limited by General Instruction I.B.6 of Form S-3.
Because our public float is below $75 million, we may not sell securities in a primary offering under this registration statement with a value exceeding one-third of our public float in any 12-month period. This limitation may restrict our ability to raise capital when needed.
The CSRC may impose fines or other sanctions on us, or prohibit or delay an offering, because we have not completed required CSRC filings.
We are required to file with the CSRC under the New Overseas Listing Rules in connection with our offerings of securities and have not yet complied with those filing requirements for offerings since its effective date on March 31, 2023. Failure to fulfill filing obligations may result in fines ranging from RMB1 million to RMB10 million and, in severe cases, the relevant responsible persons may be barred from entering the securities market. The CSRC or other PRC authorities could also take actions that limit or hinder our ability to complete offerings under this prospectus.
We have identified a material weakness in our internal control over financial reporting.
Our management concluded that our disclosure controls and procedures and our internal control over financial reporting were not effective as of December 31, 2025 due to a material weakness relating to our lack of U.S. GAAP and SEC reporting experience. If we fail to remediate the material weakness, we may be unable to accurately report our financial results, which could cause investors to lose confidence in our reported financial information.
You may have difficulty effecting service of process or enforcing judgments against us or our management.
All of our officers and directors, other than Mingjie Zhao, reside outside the United States, and all of our subsidiaries and assets are located outside the United States. As a result, it may be difficult for investors to effect service of process within the United States or to enforce judgments obtained in U.S. courts against us or our officers and directors. See “Enforceability of Civil Liabilities.”
4
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus, any applicable prospectus supplement and the documents incorporated by reference contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Exchange Act. Forward-looking statements may be identified by words such as “believe,” “expect,” “anticipate,” “should,” “planned,” “will,” “may,” “intend,” “estimated,” “aim,” “target,” “predict,” “project,” “seek,” “would,” “could,” “continue” and “potential,” among others.
Important factors that could cause actual results to differ materially from forward-looking statements include, among others: fluctuations in the supply of products from our suppliers; the expected growth of the supply chain financing industry in China, brokerage and investment banking business in Hong Kong and the global financial technology industry; changes in general economic conditions; changes in U.S., China and global financial and equity markets; our success in implementing our business strategy and integrating acquired businesses; our ability to attract and retain customers; completion of the settlement payment with FT Global Capital, Inc. and other proceedings; the results of future financing efforts; and risks associated with conducting business internationally and especially in the PRC. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except as required by law, we undertake no obligation to update any forward-looking statement.
5
USE OF PROCEEDS
Unless otherwise indicated in the applicable prospectus supplement, we intend to use the net proceeds from the sale of securities offered by this prospectus for general corporate purposes, which may include, among other things, repayment of debt, capital expenditures, the financing of possible acquisitions or business expansions, increasing our working capital and the financing of ongoing operating expenses and overhead. We have not determined the amounts we plan to spend on any of these areas or the timing of such expenditures. Pending use of the net proceeds, we may invest the proceeds in short-term, investment-grade, interest-bearing instruments. To the extent we transfer proceeds to our PRC subsidiaries, such transfers will be subject to PRC regulations on capital contributions and shareholder loans.
DESCRIPTION OF CAPITAL STOCK
The following summary of our capital stock is based on our Second Amended and Restated Articles of Incorporation, as amended (our “Articles of Incorporation”), our Amended and Restated Bylaws dated August 6, 2025 (our “Bylaws”), and the Florida Business Corporation Act (the “FBCA”). This summary is not complete and is qualified in its entirety by reference to our Articles of Incorporation and Bylaws, which are filed as exhibits to the registration statement of which this prospectus is a part.
Authorized Capital Stock
Our authorized capital stock consists of 9,375,000 shares of common stock, par value $0.001 per share, and 10,000,000 shares of preferred stock. As of November 17, 2026, there were 8,674,730 shares of common stock issued and outstanding held by approximately 53 holders of record, and no shares of preferred stock were issued and outstanding.
Common Stock
Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of shareholders. Subject to preferences that may apply to any outstanding preferred stock, holders of common stock are entitled to receive ratably such dividends as may be declared by our board of directors out of funds legally available therefor, and, upon our liquidation, dissolution or winding up, to share ratably in all assets remaining after payment of liabilities and the liquidation preference of any outstanding preferred stock. Except a greater plurality is required by the express requirements of law or our Articles of Incorporation, the affirmative vote of a majority of the shares of voting stock represented at a meeting of shareholders at which there shall be a quorum present shall be required to authorize all matters to be voted upon by our shareholders. According to our charter documents, holders of our Common Stock do not have preemptive rights and are not entitled to cumulative voting rights. There are no conversion or redemption rights or sinking funds provided for our shareholders. All issued and outstanding shares of Common Stock are fully paid and nonassessable. Shares of our Common Stock that may be offered for sale, from time to time, under this prospectus will be fully paid and nonassessable.
We have never declared or paid any cash dividends on our common stock and do not anticipate paying dividends in the foreseeable future.
6
Preferred Stock
Our board of directors is authorized, without further action by our shareholders, to issue shares of preferred stock in one or more series and, by filing articles of amendment or a certificate of designations under Florida law, to fix the designations, powers, preferences and rights of each series and the qualifications, limitations or restrictions thereof, including dividend rights, conversion rights, voting rights, redemption terms and liquidation preferences. The issuance of preferred stock could adversely affect the voting power and other rights of holders of common stock and could have the effect of delaying, deferring or preventing a change of control. The particular terms of any series of preferred stock we offer will be described in the applicable prospectus supplement.
Anti-Takeover Effects of Florida Law and Our Charter Documents
Certain provisions of the FBCA and our Articles of Incorporation and Bylaws could have the effect of delaying, deferring or discouraging another party from acquiring control of us, including provisions that:
| ● | authorize the issuance of “blank check” preferred stock that could be issued by our board of directors to thwart a takeover attempt; |
| ● | require that directors only be removed from office by the affirmative vote of the holders of a majority or more of the combined voting power of the then outstanding shares of capital of the Company entitled to vote at a meeting of shareholders called for that purpose, voting together as a single class; |
| ● | shareholders may not cumulate their votes in the election of directors; |
| ● | shareholders have no preemptive rights, and the Board may issue shares without first offering them to existing shareholders; |
| ● | the board of directors alone fixes the number of directors; |
| ● | provide that vacancies on the board of directors, including newly created directorships, may be filled by a majority vote of directors then in office; |
| ● | limit who may call special meetings of shareholders; and |
| ● | establish advance notice procedures for shareholder proposals and director nominations. |
7
The FBCA provides that “control shares” of an “issuing public corporation” acquired in a “control-share acquisition” have the same voting rights as other shares only to the extent the shareholders grant those rights by resolution. To pass, the resolution must be approved by a majority of all votes entitled to be cast by each class or series entitled to vote separately on the proposal. It must also be approved by a majority of those votes excluding all “interested shares”. Interested shares are shares voted or directed by the acquiring person or any member of its group, by any officer of the corporation, or by any employee of the corporation who is also a director. An “issuing public corporation” is a corporation that has: (i) one hundred or more shareholders; (ii) its principal place of business, its principal office, or substantial assets in Florida; and (iii) either more than 10% of its shareholders resident in Florida, more than 10% of its shares owned by Florida residents, or one thousand shareholders resident in Florida. Shares held by banks (except as trustee or guardian), brokers or nominees are disregarded in these calculations. Control shares” are shares that, when added to all other shares the person owns or whose voting it can exercise or direct, would entitle that person, immediately after the acquisition, to exercise voting power in the election of directors within any of the following ranges, whether directly or indirectly, alone or as part of a group: (i) one-fifth or more but less than one-third of all voting power; (ii) one-third or more but less than a majority of all voting power; or (iii) a majority or more of all voting power. Shares acquired within 90 days before or after the acquisition that results in a control-share acquisition, or acquired under a plan to make one, are treated as acquired in the same acquisition. An acquisition is not a control-share acquisition if it is made under certain exempt circumstances. These include an agreement of merger or plan of share exchange effected in compliance with the FBCA to which the corporation is a party, and an acquisition approved by the corporation’s board of directors before the acquisition. Currently, our principal place of business, principal office, or substantial assets are not in Florida.
The FBCA generally prohibits a Florida corporation from engaging in an “affiliated transaction” with an “interested shareholder” for three years after the shareholder becomes an interested shareholder. Affiliated transactions include certain mergers, consolidations, asset dispositions, share issuances, liquidations, reclassifications and other specified transactions. The prohibition does not apply if any of the following is met: (a) before the shareholder became an interested shareholder, the board of directors approved either the affiliated transaction or the transaction that resulted in the shareholder becoming an interested shareholder; (b) upon consummation of the transaction that made the shareholder an interested shareholder, it owned at least 85% of the voting shares outstanding when the transaction commenced. Shares held by persons who are both directors and officers, and by employee stock plans whose participants cannot confidentially decide whether to tender, are excluded from the outstanding count; or (c) at or after the time the shareholder became an interested shareholder, the affiliated transaction is approved by the board of directors and authorized at an annual or special meeting of shareholders, and not by written consent, by at least two-thirds of the outstanding voting shares not owned by the interested shareholder. An “interested shareholder” is generally any person who beneficially owns more than 15% of the corporation’s outstanding voting shares, subject to certain exclusions. In determining beneficial ownership, a person’s shares are aggregated with those of its affiliates and associates. The voting requirements described above do not apply to a particular affiliated transaction if any of the following conditions is met: (i) a majority of the disinterested directors has approved the transaction; (ii) the corporation has not had more than 300 shareholders of record at any time during the three years before the announcement date; (iii) the interested shareholder has beneficially owned at least 80% of the corporation’s outstanding voting shares for at least three years before the announcement date; (iv) the interested shareholder beneficially owns at least 90% of the outstanding voting shares, excluding shares acquired directly from the corporation in a transaction not approved by a majority of the disinterested directors; (v) the corporation is an investment company registered under the Investment Company Act of 1940; or (vi) the consideration paid to holders of each class or series of voting shares meets the minimum price, form-of-consideration and other requirements set out in the FBCA.
Transfer Agent and Registrar
The transfer agent and registrar for our common stock is Transhare Corporation at 17755 North US Highway 19 Suite 140, Clearwater, FL 33764.
Listing
Our common stock is listed on the Nasdaq Capital Market under the symbol “FTFT.”
8
DESCRIPTION OF WARRANTS
We may issue warrants for the purchase of Common Stock and/or preferred stock in one or more series. We may issue warrants independently or together with Common Stock and/or preferred stock and the warrants may be attached to or separate from these securities. While the terms summarized below will apply generally to any warrants that we may offer, we will describe the particular terms of any series of warrants in more detail in the applicable prospectus supplement. The terms of any warrants offered under a prospectus supplement may differ from the terms described below.
We will file as exhibits to the Registration Statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the SEC, the form of warrant agreement, including a form of warrant certificate, that describes the terms of the particular series of warrants we are offering. The following summaries of material provisions of the warrants and the warrant agreements are subject to, and qualified in their entirety by reference to, all the provisions of the warrant agreement and warrant certificate applicable to the particular series of warrants that we may offer under this prospectus. We urge you to read the applicable prospectus supplements related to the particular series of warrants that we may offer under this prospectus, as well as any related free writing prospectuses, and the complete warrant agreements and warrant certificates that contain the terms of the warrants.
General
We will describe in the applicable prospectus supplement the terms of the series of warrants being offered, including:
| ● | the offering price and aggregate number of warrants offered; |
| ● | the currency for which the warrants may be purchased; |
| ● | if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security; |
| ● | if applicable, the date on and after which the warrants and the related securities will be separately transferable; |
| ● | in the case of warrants to purchase Common Stock or preferred stock, the number of shares of Common Stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise; |
| ● | the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreements and the warrants; |
| ● | the terms of any rights to redeem or call the warrants; |
| ● | any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants; |
9
| ● | the dates on which the right to exercise the warrants will commence and expire; |
| ● | the manner in which the warrant agreements and warrants may be modified; |
| ● | the terms of the securities issuable upon exercise of the warrants; and |
| ● | any other specific terms, preferences, rights or limitations of or restrictions on the warrants. |
Before exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including in the case of warrants to purchase Common Stock or preferred stock, the right to receive dividends, if any, or payments upon our liquidation, dissolution or winding up or to exercise voting rights, if any.
Exercise of Warrants
Each warrant will entitle the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable prospectus supplement. Holders of the warrants may exercise the warrants at any time up to the specified time on the expiration date that we set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.
Holders of the warrants may exercise the warrants by delivering the warrant certificate representing the warrants to be exercised together with specified information, and paying the required amount to the Company in immediately available funds, as provided in the applicable prospectus supplement. We will set forth in the warrant certificate and in the applicable prospectus supplement the information that the holder of the warrant will be required to deliver to the Company for warrant exercise.
If fewer than all of the warrants represented by the warrant certificate are exercised, then we will issue a new warrant certificate for the remaining amount of warrants. If we so indicate in the applicable prospectus supplement, holders of the warrants may surrender securities as all or part of the exercise price for warrants.
10
DESCRIPTION OF RIGHTS
We may issue rights to purchase shares of our common stock or shares of our preferred stock. We may issue rights independently or together with any other offered security, which may or may not be transferable by the shareholder. In connection with any offering of rights, we may enter into a standby arrangement with one or more underwriters or other purchasers pursuant to which the underwriters or other purchasers may be required to purchase any securities remaining unsubscribed for after such offering.
The prospectus supplement relating to any rights we may offer will contain the specific terms of the subscription rights. These terms may include the following:
| ● | the price, if any, for the rights; |
| ● | the number and terms of each share of common stock or preferred stock which may be purchased per each right; |
| ● | the exercise price payable for each share of common stock or preferred stock upon the exercise of the rights; |
| ● | the extent to which the rights are transferable; |
| ● | any provisions for adjustment of the number or amount of securities receivable upon exercise of the rights or the exercise price of the rights; |
| ● | any other terms of the rights, including the terms, procedures and limitations relating to the exchange and exercise of the rights; |
| ● | the date on which the right to exercise the rights shall commence, and the date on which the rights shall expire; |
| ● | the extent to which the rights may include an over-subscription privilege with respect to unsubscribed securities; and |
| ● | if applicable, the material terms of any standby underwriting or purchase arrangement entered into by us in connection with the offering of rights. |
The description in an accompanying prospectus supplement of any rights we offer will not necessarily be complete and will be qualified in its entirety by reference to the applicable rights certificate or agreement, which will be filed with the SEC if we offer rights. For more information on how you can obtain copies of any rights certificate or subscription agreement if we offer rights, see “Where You Can Find More Information.” We urge you to read the applicable rights certificate, the applicable rights agreement and any accompanying prospectus supplement in their entirety.
11
DESCRIPTION OF UNITS
We may issue units consisting of any combination of the other securities described in this prospectus in one or more series. Each unit will be issued so that the holder is also the holder of each security included in the unit. The applicable prospectus supplement will describe the terms of the units, including the securities comprising the units, whether and when those securities may be held or transferred separately, any unit agreement under which the units will be issued, and any provisions for the issuance, payment, settlement, transfer or exchange of the units.
PLAN OF DISTRIBUTION
We may sell the securities offered by this prospectus from time to time in one or more transactions, including: to or through underwriters, brokers or dealers; through agents; directly to one or more purchasers; through “at the market” offerings within the meaning of Rule 415(a)(4) under the Securities Act to or through a market maker or into an existing trading market; through a combination of any of these methods; or through any other method permitted by applicable law. We may sell the securities at a fixed price or prices, which may be changed, at market prices prevailing at the time of sale, at prices related to prevailing market prices, or at negotiated prices.
The applicable prospectus supplement will describe the terms of the offering, including the names of any underwriters, dealers or agents; the purchase price and the proceeds we will receive; any underwriting discounts, commissions and other items constituting compensation; the public offering price; and any securities exchange on which the securities may be listed. Underwriters, dealers and agents that participate in the distribution may be deemed to be “underwriters” under the Securities Act. We may agree to indemnify underwriters, dealers and agents against certain liabilities, including liabilities under the Securities Act, and to reimburse them for certain expenses.
So long as our public float is less than $75,000,000, the aggregate market value of securities sold by us or on our behalf pursuant to General Instruction I.B.6 of Form S-3 during any 12-month period will not exceed one-third of our public float, calculated in accordance with that instruction. Any underwriter may engage in over-allotment, stabilizing transactions, short-covering transactions and penalty bids in accordance with Regulation M under the Exchange Act.
12
ENFORCEABILITY OF CIVIL LIABILITIES
We are incorporated in Florida; however, substantially all of our assets and the assets of our subsidiaries are located outside the United States, principally in the PRC and Hong Kong. In addition, all of our directors and officers, other than Mingjie Zhao, reside outside the United States, and Hu Li, Ting Ouyang, Mingyong Hu and David Xu reside in the PRC. As a result, it may be difficult for investors to effect service of process within the United States upon these persons, or to enforce against us or them judgments obtained in U.S. courts, including judgments predicated upon the civil liability provisions of the U.S. federal securities laws.
Our PRC counsel Fengdong Law Firm has advised us that the recognition and enforcement of foreign judgments are subject to compliance with the PRC Civil Procedures Law and relevant civil procedure requirements in the PRC. PRC courts may recognize and enforce foreign judgments in accordance with the requirements of the PRC Civil Procedures Law based either on treaties between China and the country where the judgment is made or on reciprocity between jurisdictions. China does not have any treaties or other form of reciprocity with the United States that provide for the reciprocal recognition and enforcement of foreign judgments.
It may also be difficult for you or overseas regulators to conduct investigations or collect evidence within China. In China, there are significant legal and other obstacles to obtain information needed for investigations or litigation originated outside China or otherwise with respect to foreign entities. Although the authorities in China may establish a regulatory cooperation mechanism with its counterparts of another country or region to monitor and oversee cross-border securities activities, such regulatory cooperation with the securities regulatory authorities may not be efficient in the absence of a practical cooperation mechanism. Furthermore, according to Article 177 of the PRC Securities Law, or “Article 177,” which became effective in March 2020, no overseas securities regulator is allowed to directly conduct investigations or evidence collection activities within the territory of the PRC. Article 177 further provides that Chinese entities and individuals are not allowed to provide documents or materials related to securities business activities to foreign agencies without prior consent from the securities regulatory authority of the State Council and the competent departments of the State Council. While detailed interpretation of or implementing rules under Article 177 have yet to be promulgated, the inability for an overseas securities regulator to directly conduct investigation or evidence collection activities within China may further increase difficulties faced by you in protecting your interests.
Although in 2017 an intermediate court of Wuhan, Hubei Province recognized and enforced the judgment from a Los Angeles Court, based on reciprocal treatment because a California court recognized and enforced a judgment of Hubei Province, China, in 2009, such recognition and enforcement is case specific and did not set as a binding precedent. There is no guarantee for further recognition and enforcement in the future. In addition, according to the PRC Civil Procedures Law, courts in the PRC will not enforce a foreign judgment against us or our directors and officers if they decide that the judgment violates the basic principles of PRC law or national sovereignty, security or public interest. As a result, it is uncertain whether and on what basis a PRC court would enforce a judgment rendered by a court in the United States. Under the PRC Civil Procedures Law, foreign shareholders may originate actions based on PRC law against us in the PRC, if they can establish sufficient nexus to the PRC for a PRC court to have jurisdiction, and meet other procedural requirements, including, among others, the plaintiff must have a direct interest in the case, and there must be a concrete claim, a factual basis and a cause for the suit.
Humphrey & Associates, our counsel as to the laws of Hong Kong, has advised us that there is uncertainty as to whether the courts of Hong Kong would (i) recognize or enforce judgments of U.S. courts obtained against us or our directors or officers predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States, or (ii) entertain original actions brought in Hong Kong against us or our directors or officers predicated upon the securities laws of the United States or any state in the United States.
A judgment of a court in the United States predicated upon U.S. federal or state securities laws may be enforced in Hong Kong at common law by bringing an action in a Hong Kong court on that judgment for the amount due thereunder and then seeking summary judgment on the strength of the foreign judgment, provided that the foreign judgment, among other things, is (1) for a debt or a definite sum of money (not being taxes or similar charges to a foreign government taxing authority or a fine or other penalty), and (2) final and conclusive on the merits of the claim, but not otherwise. Such a judgment may not, in any event, be so enforced in Hong Kong if (a) it was obtained by fraud, (b) the proceedings in which the judgment was obtained were opposed to natural justice, (c) its enforcement or recognition would be contrary to the public policy of Hong Kong, (d) the court of the United States was not jurisdictionally competent, or (e) the judgment was in conflict with a prior Hong Kong judgment.
Hong Kong has no arrangement for the reciprocal enforcement of judgments with the United States. As a result, there is uncertainty as to the enforceability in Hong Kong, in original actions or in actions for enforcement, of judgments of U.S. courts of civil liabilities predicated solely upon the federal securities laws of the United States or the securities laws of any state or territory within the United States.
We have appointed Cogency Global Inc. as our agent to receive service of process with respect to any action brought against us in connection with this offering.
13
LEGAL MATTERS
The validity of the securities offered by this prospectus will be passed upon for us by FisherBroyles, LLP. Certain legal matters relating to PRC law will be passed upon for us by Fengdong Law Firm, and certain matters relating to Hong Kong law will be passed upon for us by Humphrey & Associates. Additional legal matters may be passed upon for any underwriters, dealers or agents by counsel named in the applicable prospectus supplement.
EXPERTS
The consolidated financial statements of Future FinTech Group Inc. as of December 31, 2025 and 2024 and for the years then ended, incorporated by reference in this prospectus from our Annual Report on Form 10-K for the year ended December 31, 2025, have been audited by Fortune CPA, Inc., an independent registered public accounting firm, as stated in its report thereon (which report includes an explanatory paragraph relating to substantial doubt about our ability to continue as a going concern), and have been so incorporated in reliance upon such report given upon the authority of such firm as experts in accounting and auditing.
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains an Internet website at http://www.sec.gov that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC, including us. Our filings are also available on our website at www.ftft.com. This prospectus is part of a registration statement on Form S-3 that we filed with the SEC and does not contain all of the information in the registration statement. Forms of the indentures and other documents establishing the terms of the offered securities are or may be filed as exhibits to the registration statement or documents incorporated by reference.
14
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
The SEC allows us to “incorporate by reference” information we file with it, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is an important part of this prospectus, and information that we file later with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below (File No. 001-34502), and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of the initial registration statement and prior to effectiveness, and after the date of this prospectus until the termination of the offering (other than information “furnished” under Item 2.02 or Item 7.01 of Form 8-K and related exhibits):
| ● | our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on March 18, 2026; |
| ● | our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026, filed with the SEC on May 15, 2026, August 14, 2026, and November 16, 2026, respectively; |
| ● | our Current Reports on Form 8-K filed with the SEC on May 26, 2026, June 15, 2026, July 8, 2026, July 9, 2026, August 4, 2026 and August 26, 2026; |
| ● | the description of our common stock contained in Exhibit 4.1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, including any amendment or report filed for the purpose of updating such description. |
We also incorporate by reference all documents that we file with the SEC on or after the effective time of this prospectus pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act and prior to the sale of all the securities registered hereunder or the termination of the registration statement. Nothing in this prospectus shall be deemed to incorporate information furnished but not filed with the SEC.
Any statement contained in this prospectus or in a document incorporated or deemed to be incorporated by reference in this prospectus shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein or in the applicable prospectus supplement or in any other subsequently filed document which also is or is deemed to be incorporated by reference modifies or supersedes the statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.
Any person, including any beneficial owner, to whom this prospectus is delivered may request copies of this prospectus and any of the documents incorporated by reference in this prospectus, without charge, by written or oral request directed to Future FinTech Group Inc. at 02B-03A, 23/F, Sino Plaza, 255-257 Gloucester Road, Causeway Bay, Hong Kong, Attention: Corporate Secretary; telephone 852-2114-1970, or from the SEC through the SEC’s website at the web address provided below.
Statements contained in this prospectus as to the contents of any contract or other documents are not necessarily complete, and in each instance you are referred to the copy of the contract or other document filed as an exhibit to the registration statement or incorporated herein, each such statement being qualified in all respects by such reference and the exhibits and schedules thereto.
15
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution.
The following table sets forth the estimated expenses in connection with the issuance and distribution of the securities being registered, other than underwriting discounts and commissions, all of which will be paid by the registrant. All amounts are estimates except the SEC registration fee.
| Registration fee | $ | 17,400 | |
| Legal fees and expenses | * | ||
| Accounting fees and expenses | * | ||
| Printing and miscellaneous expenses | * | ||
| Total expenses | $ | * |
| * | Estimated expenses are presently not known and cannot be estimated. |
Item 15. Indemnification of Directors and Officers.
Section 607.0850 of the Florida Business Corporation Act permits a Florida corporation to indemnify its directors and officers in certain circumstances against expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with proceedings if the person acted in good faith and in a manner the person reasonably believed to be in, or not opposed to, the best interests of the corporation and, with respect to criminal proceedings, had no reasonable cause to believe the conduct was unlawful. Florida law also permits a corporation to advance expenses and to purchase and maintain insurance on behalf of directors and officers.
Article VIII of our Second Amended and Restated Articles of Incorporation, as amended, authorizes us, among other things, to indemnify our officers, directors, employees or agents against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by them in connection with certain actions, suits or proceedings if they acted in good faith and in a manner in which they reasonably believed to be in or not opposed to our best interests and, with respect to any criminal action or proceeding, have no reasonable cause to believe their conduct was unlawful.
Article VII of our Amended and Restated Bylaws authorizes us to indemnify our officers (subject to the Board’s discretion) and directors to the fullest extent authorized or permitted by the Florida Business Corporation Act. Our Bylaws provide that we will indemnify our directors and officers from liabilities incurred by them in connection with actions, suits or proceedings in which they are involved by reason of their acting as our directors and officers (subject to the Board’s discretion).
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that, in the opinion of the Commission, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by us of expenses incurred or paid by our director, officer or controlling person in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by us is against public policy as expressed hereby in the Securities Act and we will be governed by the final adjudication of such issue.
II-1
Item 16. Exhibits.
The exhibits listed below are filed (except where otherwise indicated) as part of this Registration Statement.
| Exhibit Number |
Description | |
| 3.1 | Second Amended and Restated Articles of Incorporation, dated June 6, 2017. Incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed with the Commission on June 9, 2017. | |
| 3.2 | Amended and Restated Bylaws. Incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed with the Commission on August 26, 2025. | |
| 3.3 | Articles of Amendment to the Articles of Incorporation of the Registrant filed with the Department of State of Florida on August 26, 2026. Incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed with the Commission on August 26, 2026. | |
| 3.4 | Articles of Amendment to the Articles of Incorporation of the Registrant filed with the Department of State of Florida on July 8, 2026. Incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed with the Commission on July 8, 2026 | |
| 3.5 | Articles of Amendment to the Articles of Incorporation of the Registrant filed with Department of State of Florida on January 8, 2026. Incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed with the Commission on January 14, 2026. | |
| 3.6 | Articles of Amendment to the Second Amended and Restated Articles of Incorporation of the Registrant filed with Department of State of Florida on September 8, 2025. Incorporated by reference to Exhibit 3.8 to our Annual Report on Form 10-K filed with the Commission on March 18, 2026. | |
| 3.7 | Articles of Amendment to the Second Amended and Restated Articles of Incorporation of the Registrant filed with Department of State of Florida on March 27, 2025. Incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed with the Commission on April 1, 2025. | |
| 3.8 | Articles of Amendment to the Second Amended and Restated Articles of Incorporation of the Registrant filed with Department of State of Florida on January 26, 2023. Incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed with the Commission on January 31, 2023. | |
| 3.9 | Articles of Amendment to the Articles of Incorporation of the Registrant filed with the Department of State of Florida on March 18, 2021. Incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed with the Commission on March 23, 2021. | |
| 3.10 | Articles of Amendment to the Articles of Incorporation of the Registrant filed with the Department of State of Florida on March 14, 2018. Incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed with the Commission on March 16, 2018. | |
| 4.1 | Form of Warrant Agreement, including form of Warrant.* | |
| 4.2 | Form of Rights Agreement* | |
| 4.3 | Form of Unit Agreement.* | |
| 5.1 | Opinion of FisherBroyles, LLP.** | |
| 23.1 | Consent of Fortune CPA Inc.** | |
| 23.2 | Consent of FisherBroyles, LLP (included in legal opinion filed as Exhibit 5.1).** | |
| 24.1 | Powers of Attorney (included on signature page).** | |
| 107 | Calculation of Filing Fee Tables** |
| * | To be filed by amendment or as an exhibit to a report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and incorporated herein by reference. |
| ** | Filed herewith. |
II-2
Item 17. Undertakings.
The undersigned registrant hereby undertakes:
| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: (i) to include any prospectus required by Section 10(a)(3) of the Securities Act; (ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” exhibit to the effective registration statement; and (iii) to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; provided, however, that paragraphs (1)(i), (1)(ii) and (1)(iii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement. |
| (2) | That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
| (3) | To remove from registration by means of a post-effective amendment any of the securities being registered that remain unsold at the termination of the offering. |
| (4) | That, for the purpose of determining liability under the Securities Act to any purchaser: (A) each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and (B) each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. |
II-3
| (5) | That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: (i) any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; (ii) any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; (iii) the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and (iv) any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
| (6) | That, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions described in Item 15, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. In the event that a claim for indemnification against such liabilities, other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person in the successful defense of any action, suit or proceeding, is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
II-4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Hong Kong, on November 18, 2026.
| FUTURE FINTECH GROUP INC. | ||
| By: | /s/ Hu Li | |
| Name: | Hu Li | |
| Title: | Chief Executive Officer and Director | |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Hu Li and Ting Ouyang, and each of them, as his or her true and lawful attorneys-in-fact and agents, each with full power of substitution and resubstitution, for such person and in such person’s name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement, including post-effective amendments and registration statements filed pursuant to Rule 462(b) under the Securities Act, and to file the same, with all exhibits thereto and all documents in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act requisite and necessary to be done, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
| Signature | Title | Date | ||
| /s/ Hu Li | Chief Executive Officer, President and Director | November 18, 2026 | ||
| Hu Li | (Principal Executive Officer) | |||
| /s/ Ting Ouyang | Chief Financial Officer and Director | November 18, 2026 | ||
| Ting Ouyang | (Principal Financial and Accounting Officer) | |||
| /s/ David Xu | Chairman of the Board and Director | November 18, 2026 | ||
| David Xu | ||||
| /s/ Mingjie Zhao | Director | November 18, 2026 | ||
| Mingjie Zhao | ||||
| /s/ Mingyong Hu | Director | November 18, 2026 | ||
| Mingyong Hu |
II-5
SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES
Pursuant to the requirements of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Future FinTech Group Inc. has signed this registration statement on November 18, 2026.
| Authorized U.S. Representative | ||
| COGENCY GLOBAL INC. | ||
| /s/ Colleen A. DeVries | ||
| Name: | Colleen A. DeVries | |
| Title: | Senior Vice President | |
II-6